-
Join 357 other subscribers
Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Clamour against United Kingdom’s free-trade negotiator
- India, EU conclude another round of talks for proposed trade agreement
- Next round of India, UK talks for free trade agreement to be held in March
- ‘Playing with the lives of HIV patients’: Drug shortages force many to change medication regime
- Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Categories
Category Archives: Ebola
Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC
Sources: Health Policy Watch 16th April, 2019 A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new … Continue reading
Posted in Ebola, Innovation, Vaccines, WHO
Leave a comment
WHO Calls For International Support After Ebola Infections Rise In DRC
Source: Health Policy Watch 15th April, 2019 The World Health Organization called on the international community to ramp up contributions to the US$ 148 million in funding required for the next six months’ Ebola outbreak response in the Democratic Republic … Continue reading
Posted in Ebola, Neglected Diseases, WHO
Leave a comment
Universal standards of care to Ebola virus disease
Source: Science Daily 12th April, 2019 Medical researchers are calling for universal standards of care to be applied in relation to Ebola virus disease. LSTM’s Senior Clinical Lecturer, Dr Shevin Jacob is corresponding author on a perspective piece published in … Continue reading
Posted in Ebola
Leave a comment
Access to Medicines Ireland seeks change in R&D approach of pharmaceutical companies
Source: Irish Times 10th April, 2019 Drug costs threaten to bankrupt healthcare, says lobby group Access to Medicines Ireland seeks change in R&D approach of pharmaceutical companies Liberian nurses carry the body of an Ebola victim in 2014. Vaccines were … Continue reading
Posted in Access to Medicins, Drug prices, Ebola, R&D
Leave a comment
G-Finder Report: Ebola Distracted R&D Funding For Neglected Diseases; Public Funding At Low
IP Watch; December 8, 2015. A newly issued report provides the “first ever” picture of global investment in Ebola research and development. The report found that investment in Ebola might have come at the expense of other funding to develop drugs, … Continue reading
Posted in Ebola, Innovation, Neglected Diseases, Public research
Leave a comment